Updated: January 23, 2026
Wixela Inhub Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
What side effects does Wixela Inhub cause? Learn about common and serious side effects of this generic Advair Diskus inhaler and when to call your doctor.
Wixela Inhub (fluticasone propionate/salmeterol) is a twice-daily maintenance inhaler for asthma and COPD. Like all medications, it can cause side effects — ranging from mild and manageable to serious and requiring medical attention. This guide covers what to expect and, importantly, when to call your doctor.
The Most Important Warning: LABA Boxed Warning
Wixela Inhub carries an FDA boxed warning (the most serious warning type) related to its salmeterol component — a long-acting beta agonist (LABA). When LABAs are used alone (without an inhaled corticosteroid), they increase the risk of asthma-related death and hospitalization. However, in Wixela Inhub the LABA (salmeterol) is combined with an ICS (fluticasone). Clinical trials have shown that this combination does NOT significantly increase the risk of serious asthma events compared to ICS therapy alone.
Key takeaway: Do NOT use Wixela Inhub with any other LABA medication. And never stop using it without your doctor's guidance.
Common Side Effects (Mild)
These side effects affect a significant percentage of users and are generally manageable:
- Oral candidiasis (thrush): Fungal infection in the mouth and throat. Appears as white patches or soreness. Prevented by rinsing your mouth with water and spitting after EVERY use of the inhaler.
- Upper respiratory tract infections: Cold-like symptoms including congestion, runny nose, and sore throat. These are among the most commonly reported side effects in clinical trials.
- Headache: Common, usually mild and resolves on its own.
- Cough and hoarseness: Related to the ICS component. Rinsing mouth with water after use helps.
- Nausea and gastrointestinal symptoms: Less common but possible, especially early in treatment.
Serious Side Effects: When to Call Your Doctor
Call your doctor if you notice any of the following:
- Pneumonia (especially if you have COPD): Symptoms include increased mucus production, change in mucus color, fever, chills, increased cough, and worsening breathing. COPD patients taking ICS/LABA inhalers have a higher risk of pneumonia than those taking LABAs alone. Call your doctor promptly if you develop these symptoms.
- Paradoxical bronchospasm: Sudden worsening of breathing immediately after inhaling Wixela Inhub. This is rare but life-threatening. Stop the inhaler and seek emergency care immediately.
- Signs of adrenal suppression: Fatigue, weakness, loss of appetite, nausea, vomiting, low blood pressure. Most likely in patients switching from oral corticosteroids to inhaled therapy.
- Serious allergic reactions: Rash, hives, swelling of the face/mouth/tongue, trouble breathing. Seek emergency care immediately.
- Heart rhythm changes: Salmeterol can cause QT prolongation. Watch for palpitations, dizziness, or fainting. Risk increases with certain medications (see our drug interactions post).
- Worsening symptoms: Using your rescue inhaler more frequently than usual or your peak flow readings declining. This may mean your maintenance dose is too low.
Go to the Emergency Room If You Experience:
- Sudden, severe shortness of breath or wheezing that your rescue inhaler does not relieve
- Paradoxical bronchospasm (breathing worsens immediately after using the inhaler)
- Signs of severe allergic reaction (throat swelling, inability to breathe)
- Chest pain with fast or irregular heartbeat
Long-Term Side Effects to Monitor
With long-term use of inhaled corticosteroids, patients should be periodically monitored for:
- Bone mineral density: Long-term ICS use may reduce bone density. DEXA scans may be recommended for high-risk patients.
- Cataracts and glaucoma: Rare but reported with high-dose, long-term inhaled corticosteroids. Regular eye exams are recommended.
- Blood glucose: ICS may cause a slight increase in blood glucose. Monitor carefully if you have diabetes.
The Bottom Line on Wixela Inhub Side Effects
For most patients, Wixela Inhub is well-tolerated. The most preventable side effect is oral thrush — completely avoidable with consistent mouth rinsing after each use. Serious side effects are rare but real, and knowing the warning signs ensures you get help quickly if needed. Also review: Wixela Inhub Drug Interactions: What to Avoid and What to Tell Your Doctor.
Frequently Asked Questions
The most common side effects of Wixela Inhub are upper respiratory tract infections, sore throat, and headache. Oral thrush (a fungal infection in the mouth) is also common but largely preventable by rinsing your mouth with water and spitting after every use of the inhaler.
Rinse your mouth with water and spit it out (do not swallow) after every single dose of Wixela Inhub. This simple step significantly reduces the risk of oral candidiasis. If you do develop thrush (white patches in your mouth, soreness), contact your doctor for an antifungal treatment — you generally do not need to stop the inhaler.
Weight gain was rarely reported in clinical trials for Wixela Inhub. Oral corticosteroids commonly cause weight gain, but inhaled corticosteroids like fluticasone propionate have much lower systemic absorption and are much less likely to cause weight gain. If you're concerned about weight changes, discuss them with your doctor.
Yes, Wixela Inhub is designed for long-term maintenance therapy and is used safely by millions of patients. With long-term use, your doctor should periodically monitor bone density, eye health, and blood glucose. Using the lowest effective dose and rinsing your mouth after each use reduces long-term risk.
The salmeterol component of Wixela Inhub can cause QT prolongation at very high doses or when combined with certain other medications. At prescribed doses, serious cardiac events are rare. However, report palpitations, rapid heartbeat, dizziness, or fainting to your doctor promptly. Avoid combining Wixela Inhub with other LABA medications or strong CYP3A4 inhibitors (like certain antifungals or HIV medications).
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Wixela Inhub also looked for:
More about Wixela Inhub
34,954 have already found their meds with Medfinder.
Start your search today.





